Govt mulling guidelines for OTC medicines; move to reduce burden on doctors

Industry players present at the event highlighted that the OTC market offers a major business opportunity, but it needs transparent and clear regulations

drugs, medical, medicine
Sanket Koul New Delhi
2 min read Last Updated : Nov 03 2023 | 10:54 PM IST
The Centre is deliberating on guidelines for over-the-counter (OTC) medicines, a senior government official said on Friday. The move, pharma associations claim, will reduce the burden on doctors and increase access to medicines.

A K Pradhan, joint drug controller at the Central Drugs Standard Control Organisation, said the issue of regulations for OTC drugs had been recognised by all the stakeholders.

“This has been under constant discussions and deliberations in our meetings. Such regulations will also need to take care of advertising, labelling, and marketing of OTC drugs,”  Pradhan said at an event by PHD Chambers of Commerce and Industry and Organisation of Pharmaceutical Producers of India in Delhi.

Sudarshan Jain, secretary general of the Indian Pharmaceutical Alliance  that represents large domestic pharma companies, called for an effort to bring the guidelines for OTC drugs into effect, said.

Industry players present at the event highlighted that the OTC market offers a major business opportunity, but it needs transparent and clear regulations.

Azadar Khan, senior vice-president at Sun Pharma, said the Indian OTC market was estimated to be around $6.5 billion, making it a huge opportunity for business. But it also needs a consumer-centric approach, Khan said. “A transparent and clear regulation will put manufacturers at ease and will have a lot of clear information available at the patient’s level. The industry side is eager to have it as these regulations will clear clouds with regards to ambiguity in interpretation,” he said.

Shivam Puri, chief executive officer at Cipla Health, pointed out that OTCs are mainly considered medicinal products and therefore need more convincing in order to have consumers use them in daily lives.

“OTC products, such as ORS, have been seen as SOS medicines needed only in case of dehydration and diarrhoea, but it can be used in place of sugar-laced energy drinks as well,” Puri said. Thus, he said, the industry feels responsible marketing practices are necessary and the guidelines would help with that.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :OTC drugsCDSCOdrugsIndian pharma

First Published: Nov 03 2023 | 10:54 PM IST

Next Story